Celgene Corp (CELG) 136.24 $CELG
Celgene Buys Receptos. Is Arena Pharmaceuticals Next?
Brian Orelli, The Motley Fool - Motley Fool - Tue Jul 21, 3:27PM CDT
Arena Pharmaceuticals (NASDAQ: ARNA) jumped more than 6% last Wednesday. But it had nothing to do with the biotech's only approved drug, obesity treatment Belviq. It wasn't even anything Arena Pharmaceuticals did. Instead, it appears the bump...
BIIB: 409.50 (+0.57), RCPT: 228.98 (+0.26), ARNA: 4.30 (-0.05), NVS: 103.71 (-2.41), CELG: 136.24 (+1.01)
What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 1:00PM CDT
Celgene Corporation (CELG) is scheduled to report second-quarter 2015 results on Jul 23, before the opening bell.
VRX: 240.59 (+0.71), ESRX: 93.42 (+1.53), MDCO: 33.85 (+0.13), CELG: 136.24 (+1.01)
Why This Analyst Expects New Alzhemier’s Trials Could Produce the Most Important Drugs in History
ESTMZ - Tue Jul 21, 11:24AM CDT
Welcome to the July 21st edition of This Week on Estimize. We are pleased to be joined by Joe McCann, former biotech analyst and founder of Slingshot Insights, a company that works to provide professional caliber investment tools to sophisticated...
BIIB: 409.50 (+0.57), SPY: 211.75 (-0.84), GILD: 117.78 (-0.42), ZGNX: 20.72 (+0.34), UTHR: 175.17 (-2.34), RTRX: 34.47 (-0.68), LLY: 85.57 (-2.30), CELG: 136.24 (+1.01), XOMA: 4.39 (-0.13)
3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results
Sean Williams, The Motley Fool - Motley Fool - Tue Jul 21, 6:03AM CDT
Source: Food and Drug Administration via Facebook. Earnings season is heating up, which means that some of healthcare's biggest names are set to report their latest quarterly results. One of the first biotech blue-chip stocks up to bat in the...
CELG: 136.24 (+1.01)
Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google
at The Street - Tue Jul 21, 5:00AM CDT
Cramer is delighted to see two of his favorite companies, Celgene and Receptos come together.
NFLX: 112.51 (+1.96), AMZN: 488.00 (-0.10), FB: 98.39 (+0.48), RCPT: 228.98 (+0.26), GOOGL: 695.35 (+2.51), CELG: 136.24 (+1.01)
Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way
at The Street - Mon Jul 20, 7:31PM CDT
Cramer says you've got to listen to the commentary on earnings from Apple tomorrow, not to mention what's up with Microsoft and falling PC sales.
WWE: 17.23 (+0.34), DAL: 44.65 (+0.56), PYPL: 39.35 (-1.12), SBUX: 56.20 (-0.01), YHOO: 39.73 (+0.19), JNJ: 100.34 (-0.03), QCOM: 65.14 (+1.35), CMG: 673.07 (-4.93), HZNP: 38.45 (+0.14), RCPT: 228.98 (+0.26), AAL: 40.90 (+0.35), ABBV: 70.54 (-0.26), GOOGL: 695.35 (+2.51), CAT: 82.22 (-0.03), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32), CSCO: 27.84 (-0.19), AMBA: 118.18 (+0.46), JOY: 29.01 (-0.59), KO: 41.19 (-0.19), AMZN: 488.00 (-0.10), ABT: 49.76 (-0.30), AXP: 78.95 (-0.35), FB: 98.39 (+0.48), LLY: 85.57 (-2.30), BA: 145.00 (-1.72), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), UA: 88.34 (-0.61), NLY: 9.77 (-0.04), MCD: 97.32 (-0.17), VGR: 24.69 (-0.14), BABA: 82.54 (-0.13)
Earnings Loom For Handful Of Top Big Cap 20 Stocks
at Investor's Business Daily - Mon Jul 20, 5:50PM CDT
A handful of Big Cap 20 stocks are due to report quarterly earnings this week, but only one is expected to post accelerating profit growth. Starbucks (SBUX) will report fiscal Q3 earnings Thursday. Profit is seen rising 21% to 41 cents a share, which...
SBUX: 56.20 (-0.01), BIIB: 409.50 (+0.57), ILMN: 237.54 (-2.48), ABBV: 70.54 (-0.26), CELG: 136.24 (+1.01)
Are Any New FANGs Baring Their Teeth?
at The Street - Mon Jul 20, 10:27AM CDT
The fearsome foursome have been reborn.
AGN: 317.00 (-0.75), AMBA: 118.18 (+0.46), NFLX: 112.51 (+1.96), BIIB: 409.50 (+0.57), GPRO: 62.04 (+1.24), AMZN: 488.00 (-0.10), VRX: 240.59 (+0.71), GILD: 117.78 (-0.42), FB: 98.39 (+0.48), GOOGL: 695.35 (+2.51), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01), MS: 40.08 (+0.04)
NFLX, CELG, M, GS: Jim Cramer's Views
at The Street - Mon Jul 20, 12:00AM CDT
Jim Cramer shares his views on chasing winners and the classical approach. Netflix, Celgene, Macy's and Goldman Sachs are among the many stocks discussed here.
HD: 113.86 (+0.45), ETH: 28.73 (-0.18), M: 71.67 (-0.47), CELG: 136.24 (+1.01), DRI: 73.01 (+0.06), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), TGT: 82.28 (-1.95), MCD: 97.32 (-0.17), RCPT: 228.98 (+0.26), GOOGL: 695.35 (+2.51), TWTR: 36.63 (+0.82), WEN: 10.27 (+0.01)
Is Celgene Brilliant or Downright Crazy?
Todd Campbell, The Motley Fool - Motley Fool - Sun Jul 19, 12:17PM CDT
Source: Flickr user DonkeyHotey. Celgene is on a spending spree that is reshaping its future, but investors are right to question whether or not the company's decision to fork over more than $8 billion in the past month is savvy or crazy....
RCPT: 228.98 (+0.26), JUNO: 50.10 (-0.03), CELG: 136.24 (+1.01)
Move Aside Apple: 8 IBD 50 Stocks With Earnings Due
at Investor's Business Daily - Sat Jul 18, 7:02AM CDT
Earnings season is now in high gear, with all eyes on Apple's (AAPL) report Tuesday. While the iPhone maker should deliver another quarter of solid profit and sales growth, Apple isn't on the IBD 50 list of the very best stocks. In the coming week,...
SBUX: 56.20 (-0.01), ABC: 114.10 (-0.66), VRX: 240.59 (+0.71), RCPT: 228.98 (+0.26), ILMN: 237.54 (-2.48), HAWK: 42.65 (-0.25), MANH: 62.33 (-0.17), ALK: 74.95 (+0.81), AAPL: 130.75 (-1.32), CELG: 136.24 (+1.01)
Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs
at The Street - Fri Jul 17, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he talks about this perilous market, why oil bears are wrong, and which sectors portfolio managers fear, but shouldn't.
BOFI: 117.83 (+0.62), MDLZ: 42.07 (+0.26), EA: 73.68 (-1.11), CAG: 44.02 (-0.27), DAL: 44.65 (+0.56), C: 59.10 (+0.25), INTC: 28.72 (-0.38), ADBE: 81.19 (-0.90), PEP: 96.93 (-0.38), RCL: 84.60 (-0.15), NOW: 78.57 (-0.27), JPM: 69.10 (-0.16), IBM: 163.07 (-10.15), VAC: 90.98 (-0.13), RCPT: 228.98 (+0.26), ABBV: 70.54 (-0.26), MSFT: 47.28 (+0.36), ACN: 100.39 (-0.33), AMZN: 488.00 (-0.10), ABT: 49.76 (-0.30), AKAM: 72.55 (-0.93), FB: 98.39 (+0.48), GME: 46.94 (+0.11), PFE: 35.14 (-0.10), DIS: 119.31 (-0.27), WFC: 57.95 (-0.10), BAC: 18.08 (-0.04), BMY: 68.87 (-1.10), GSK: 42.63 (-0.39), CSX: 31.86 (-0.14), HPQ: 30.66 (+0.21), ORCL: 39.57 (-0.36), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), MRK: 58.67 (-0.33), RHT: 78.29 (-0.90), DATA: 127.57 (-0.58), GIS: 57.21 (+0.38), CRM: 73.83 (+1.06)
Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor
at The Street - Fri Jul 17, 6:00PM CDT
Cramer's first rule: Diversification is the only way to invest.
DUK: 72.42 (-0.85), SVU: 7.73 (-0.05), FB: 98.39 (+0.48), SKT: 32.65 (-0.06), ED: 61.48 (+0.08), FRT: 135.23 (-1.08), RSH: 0.24 (-0.04), PLKI: 58.73 (-0.28), CELG: 136.24 (+1.01), RAD: 8.69 (-0.13), T: 34.57 (-0.33), S: 3.77 (-0.04), CMG: 673.07 (-4.93), GLD: 105.37 (-0.33), GOOGL: 695.35 (+2.51), VZ: 46.97 (-1.13), AAPL: 130.75 (-1.32), REGN: 560.00 (-1.17)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Receptos, Inc. Concerning its Proposed Sale to Celgene Corporation
Business Wire - Fri Jul 17, 5:52PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Receptos, Inc. (NASDAQ: RCPT) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Receptos to maximize shareholder value before agreeing to be acquired by Celgene Corporation (NASDAQ: CELG).
RCPT: 228.98 (+0.26), CELG: 136.24 (+1.01), CELGZ: 2.19 (+0.01)
Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 71.78 (-2.82), AMBA: 118.18 (+0.46), MNST: 144.05 (+1.30), VRX: 240.59 (+0.71), ILMN: 237.54 (-2.48), RCPT: 228.98 (+0.26), HAWK: 42.65 (-0.25), FLTX: 49.64 (-0.24), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Which Top Biotechs Still In Play After Celgene Rally?
at Investor's Business Daily - Thu Jul 16, 5:45PM CDT
This week's list of leading stocks near buy points includes a healthy dose of medical names, from biotechs to managed care providers. The biotech revival began prior to Celgene's (CELG) 7% jump Wednesday on its $7.2 billion buy of Receptos (RCPT)....
MNK: 123.98 (+1.04), AGN: 317.00 (-0.75), VRX: 240.59 (+0.71), GILD: 117.78 (-0.42), UTHR: 175.17 (-2.34), RCPT: 228.98 (+0.26), MOH: 72.56 (-0.42), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Citigroup and Netflix are big market movers
AP - Thu Jul 16, 3:24PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
DAL: 44.65 (+0.56), C: 59.10 (+0.25), GRMN: 42.67 (+0.16), XOM: 81.66 (-0.10), BAC: 18.08 (-0.04), CSX: 31.86 (-0.14), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), PM: 85.54 (-0.07), SON: 41.14 (-0.33), MJN: 88.13 (+0.32), EBAY: 28.60 (+0.03), SRCL: 133.42 (-1.76), SHW: 266.99 (-0.63)
Celgene's $7.2 Billion Makes a Big Splash
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Thu Jul 16, 3:02PM CDT
Celgene 's purchase of Juno for a whopping $7.2 billion highlights that CAR-T drug possibilities are growing in appeal. What's behind the acquisition, and where does Juno fit into Celgene's bigger picture? A full transcript follows the video. ...
JUNO: 50.10 (-0.03), CELG: 136.24 (+1.01)
What Are Portfolio Managers Afraid Of?
at The Street - Thu Jul 16, 1:51PM CDT
They should learn to trust techs, financials.
DAL: 44.65 (+0.56), FB: 98.39 (+0.48), C: 59.10 (+0.25), PFE: 35.14 (-0.10), BAC: 18.08 (-0.04), WFC: 57.95 (-0.10), GSK: 42.63 (-0.39), INTC: 28.72 (-0.38), CSX: 31.86 (-0.14), HPQ: 30.66 (+0.21), ORCL: 39.57 (-0.36), PEP: 96.93 (-0.38), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), NOW: 78.57 (-0.27), JPM: 69.10 (-0.16), IBM: 163.07 (-10.15), MRK: 58.67 (-0.33), RCPT: 228.98 (+0.26), MSFT: 47.28 (+0.36), DATA: 127.57 (-0.58), CRM: 73.83 (+1.06)
Why I Won't Chase Netflix or Celgene Now
at The Street - Thu Jul 16, 12:11PM CDT
It's like buying at the top -- and I don't like buying at the top.
NFLX: 112.51 (+1.96), RCPT: 228.98 (+0.26), CELG: 136.24 (+1.01)
Celgene Buys Receptos. Is Arena Pharmaceuticals Next?
Brian Orelli, The Motley Fool - Motley Fool - Tue Jul 21, 3:27PM CDT
Arena Pharmaceuticals (NASDAQ: ARNA) jumped more than 6% last Wednesday. But it had nothing to do with the biotech's only approved drug, obesity treatment Belviq. It wasn't even anything Arena Pharmaceuticals did. Instead, it appears the bump...
BIIB: 409.50 (+0.57), RCPT: 228.98 (+0.26), ARNA: 4.30 (-0.05), NVS: 103.71 (-2.41), CELG: 136.24 (+1.01)
What's in Store for Celgene (CELG) This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 21, 1:00PM CDT
Celgene Corporation (CELG) is scheduled to report second-quarter 2015 results on Jul 23, before the opening bell.
VRX: 240.59 (+0.71), ESRX: 93.42 (+1.53), MDCO: 33.85 (+0.13), CELG: 136.24 (+1.01)
Why This Analyst Expects New Alzhemier’s Trials Could Produce the Most Important Drugs in History
ESTMZ - Tue Jul 21, 11:24AM CDT
Welcome to the July 21st edition of This Week on Estimize. We are pleased to be joined by Joe McCann, former biotech analyst and founder of Slingshot Insights, a company that works to provide professional caliber investment tools to sophisticated...
BIIB: 409.50 (+0.57), SPY: 211.75 (-0.84), GILD: 117.78 (-0.42), ZGNX: 20.72 (+0.34), UTHR: 175.17 (-2.34), RTRX: 34.47 (-0.68), LLY: 85.57 (-2.30), CELG: 136.24 (+1.01), XOMA: 4.39 (-0.13)
3 Questions Investors Should Ask When Celgene Reports Its Second-Quarter Results
Sean Williams, The Motley Fool - Motley Fool - Tue Jul 21, 6:03AM CDT
Source: Food and Drug Administration via Facebook. Earnings season is heating up, which means that some of healthcare's biggest names are set to report their latest quarterly results. One of the first biotech blue-chip stocks up to bat in the...
CELG: 136.24 (+1.01)
Jim Cramer's Top Takeaways: Celgene, Facebook, Amazon.com, Netflix, Google
at The Street - Tue Jul 21, 5:00AM CDT
Cramer is delighted to see two of his favorite companies, Celgene and Receptos come together.
NFLX: 112.51 (+1.96), AMZN: 488.00 (-0.10), FB: 98.39 (+0.48), RCPT: 228.98 (+0.26), GOOGL: 695.35 (+2.51), CELG: 136.24 (+1.01)
Jim Cramer's 'Mad Money' Recap: Earnings Tsunami Heads Our Way
at The Street - Mon Jul 20, 7:31PM CDT
Cramer says you've got to listen to the commentary on earnings from Apple tomorrow, not to mention what's up with Microsoft and falling PC sales.
WWE: 17.23 (+0.34), DAL: 44.65 (+0.56), PYPL: 39.35 (-1.12), SBUX: 56.20 (-0.01), YHOO: 39.73 (+0.19), JNJ: 100.34 (-0.03), QCOM: 65.14 (+1.35), CMG: 673.07 (-4.93), HZNP: 38.45 (+0.14), RCPT: 228.98 (+0.26), AAL: 40.90 (+0.35), ABBV: 70.54 (-0.26), GOOGL: 695.35 (+2.51), CAT: 82.22 (-0.03), MSFT: 47.28 (+0.36), AAPL: 130.75 (-1.32), CSCO: 27.84 (-0.19), AMBA: 118.18 (+0.46), JOY: 29.01 (-0.59), KO: 41.19 (-0.19), AMZN: 488.00 (-0.10), ABT: 49.76 (-0.30), AXP: 78.95 (-0.35), FB: 98.39 (+0.48), LLY: 85.57 (-2.30), BA: 145.00 (-1.72), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), UA: 88.34 (-0.61), NLY: 9.77 (-0.04), MCD: 97.32 (-0.17), VGR: 24.69 (-0.14), BABA: 82.54 (-0.13)
Earnings Loom For Handful Of Top Big Cap 20 Stocks
at Investor's Business Daily - Mon Jul 20, 5:50PM CDT
A handful of Big Cap 20 stocks are due to report quarterly earnings this week, but only one is expected to post accelerating profit growth. Starbucks (SBUX) will report fiscal Q3 earnings Thursday. Profit is seen rising 21% to 41 cents a share, which...
SBUX: 56.20 (-0.01), BIIB: 409.50 (+0.57), ILMN: 237.54 (-2.48), ABBV: 70.54 (-0.26), CELG: 136.24 (+1.01)
Are Any New FANGs Baring Their Teeth?
at The Street - Mon Jul 20, 10:27AM CDT
The fearsome foursome have been reborn.
AGN: 317.00 (-0.75), AMBA: 118.18 (+0.46), NFLX: 112.51 (+1.96), BIIB: 409.50 (+0.57), GPRO: 62.04 (+1.24), AMZN: 488.00 (-0.10), VRX: 240.59 (+0.71), GILD: 117.78 (-0.42), FB: 98.39 (+0.48), GOOGL: 695.35 (+2.51), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01), MS: 40.08 (+0.04)
NFLX, CELG, M, GS: Jim Cramer's Views
at The Street - Mon Jul 20, 12:00AM CDT
Jim Cramer shares his views on chasing winners and the classical approach. Netflix, Celgene, Macy's and Goldman Sachs are among the many stocks discussed here.
HD: 113.86 (+0.45), ETH: 28.73 (-0.18), M: 71.67 (-0.47), CELG: 136.24 (+1.01), DRI: 73.01 (+0.06), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), TGT: 82.28 (-1.95), MCD: 97.32 (-0.17), RCPT: 228.98 (+0.26), GOOGL: 695.35 (+2.51), TWTR: 36.63 (+0.82), WEN: 10.27 (+0.01)
Is Celgene Brilliant or Downright Crazy?
Todd Campbell, The Motley Fool - Motley Fool - Sun Jul 19, 12:17PM CDT
Source: Flickr user DonkeyHotey. Celgene is on a spending spree that is reshaping its future, but investors are right to question whether or not the company's decision to fork over more than $8 billion in the past month is savvy or crazy....
RCPT: 228.98 (+0.26), JUNO: 50.10 (-0.03), CELG: 136.24 (+1.01)
Move Aside Apple: 8 IBD 50 Stocks With Earnings Due
at Investor's Business Daily - Sat Jul 18, 7:02AM CDT
Earnings season is now in high gear, with all eyes on Apple's (AAPL) report Tuesday. While the iPhone maker should deliver another quarter of solid profit and sales growth, Apple isn't on the IBD 50 list of the very best stocks. In the coming week,...
SBUX: 56.20 (-0.01), ABC: 114.10 (-0.66), VRX: 240.59 (+0.71), RCPT: 228.98 (+0.26), ILMN: 237.54 (-2.48), HAWK: 42.65 (-0.25), MANH: 62.33 (-0.17), ALK: 74.95 (+0.81), AAPL: 130.75 (-1.32), CELG: 136.24 (+1.01)
Risks and Rewards; Oil Optimism; and the Winners Portfolio Managers Are Missing: Jim Cramer's Best Blogs
at The Street - Fri Jul 17, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he talks about this perilous market, why oil bears are wrong, and which sectors portfolio managers fear, but shouldn't.
BOFI: 117.83 (+0.62), MDLZ: 42.07 (+0.26), EA: 73.68 (-1.11), CAG: 44.02 (-0.27), DAL: 44.65 (+0.56), C: 59.10 (+0.25), INTC: 28.72 (-0.38), ADBE: 81.19 (-0.90), PEP: 96.93 (-0.38), RCL: 84.60 (-0.15), NOW: 78.57 (-0.27), JPM: 69.10 (-0.16), IBM: 163.07 (-10.15), VAC: 90.98 (-0.13), RCPT: 228.98 (+0.26), ABBV: 70.54 (-0.26), MSFT: 47.28 (+0.36), ACN: 100.39 (-0.33), AMZN: 488.00 (-0.10), ABT: 49.76 (-0.30), AKAM: 72.55 (-0.93), FB: 98.39 (+0.48), GME: 46.94 (+0.11), PFE: 35.14 (-0.10), DIS: 119.31 (-0.27), WFC: 57.95 (-0.10), BAC: 18.08 (-0.04), BMY: 68.87 (-1.10), GSK: 42.63 (-0.39), CSX: 31.86 (-0.14), HPQ: 30.66 (+0.21), ORCL: 39.57 (-0.36), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), MRK: 58.67 (-0.33), RHT: 78.29 (-0.90), DATA: 127.57 (-0.58), GIS: 57.21 (+0.38), CRM: 73.83 (+1.06)
Jim Cramer's 'Mad Money' Recap: How to Become an Even Better Investor
at The Street - Fri Jul 17, 6:00PM CDT
Cramer's first rule: Diversification is the only way to invest.
DUK: 72.42 (-0.85), SVU: 7.73 (-0.05), FB: 98.39 (+0.48), SKT: 32.65 (-0.06), ED: 61.48 (+0.08), FRT: 135.23 (-1.08), RSH: 0.24 (-0.04), PLKI: 58.73 (-0.28), CELG: 136.24 (+1.01), RAD: 8.69 (-0.13), T: 34.57 (-0.33), S: 3.77 (-0.04), CMG: 673.07 (-4.93), GLD: 105.37 (-0.33), GOOGL: 695.35 (+2.51), VZ: 46.97 (-1.13), AAPL: 130.75 (-1.32), REGN: 560.00 (-1.17)
EQUITY ALERT: The Rosen Law Firm Announces Investigation of Receptos, Inc. Concerning its Proposed Sale to Celgene Corporation
Business Wire - Fri Jul 17, 5:52PM CDT
The Rosen Law Firm, a global investor rights law firm, announces that it is investigating the Board of Directors of Receptos, Inc. (NASDAQ: RCPT) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Receptos to maximize shareholder value before agreeing to be acquired by Celgene Corporation (NASDAQ: CELG).
RCPT: 228.98 (+0.26), CELG: 136.24 (+1.01), CELGZ: 2.19 (+0.01)
Newfound Market Strength Could Benefit These IBD 50 Names
at Investor's Business Daily - Fri Jul 17, 5:48PM CDT
The stock market often does what's least expected, and that certainly has been the case lately. Consider these four recent occurrences: A heavy distribution-day count for the Nasdaq and S&P 500 in recent weeks didn't do much damage to the market. In...
CNC: 71.78 (-2.82), AMBA: 118.18 (+0.46), MNST: 144.05 (+1.30), VRX: 240.59 (+0.71), ILMN: 237.54 (-2.48), RCPT: 228.98 (+0.26), HAWK: 42.65 (-0.25), FLTX: 49.64 (-0.24), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Which Top Biotechs Still In Play After Celgene Rally?
at Investor's Business Daily - Thu Jul 16, 5:45PM CDT
This week's list of leading stocks near buy points includes a healthy dose of medical names, from biotechs to managed care providers. The biotech revival began prior to Celgene's (CELG) 7% jump Wednesday on its $7.2 billion buy of Receptos (RCPT)....
MNK: 123.98 (+1.04), AGN: 317.00 (-0.75), VRX: 240.59 (+0.71), GILD: 117.78 (-0.42), UTHR: 175.17 (-2.34), RCPT: 228.98 (+0.26), MOH: 72.56 (-0.42), REGN: 560.00 (-1.17), CELG: 136.24 (+1.01)
Citigroup and Netflix are big market movers
AP - Thu Jul 16, 3:24PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Thursday on the New York Stock Exchange and the Nasdaq Stock Market:
DAL: 44.65 (+0.56), C: 59.10 (+0.25), GRMN: 42.67 (+0.16), XOM: 81.66 (-0.10), BAC: 18.08 (-0.04), CSX: 31.86 (-0.14), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), PM: 85.54 (-0.07), SON: 41.14 (-0.33), MJN: 88.13 (+0.32), EBAY: 28.60 (+0.03), SRCL: 133.42 (-1.76), SHW: 266.99 (-0.63)
Celgene's $7.2 Billion Makes a Big Splash
Todd Campbell and Michael Douglass, The Motley Fool - Motley Fool - Thu Jul 16, 3:02PM CDT
Celgene 's purchase of Juno for a whopping $7.2 billion highlights that CAR-T drug possibilities are growing in appeal. What's behind the acquisition, and where does Juno fit into Celgene's bigger picture? A full transcript follows the video. ...
JUNO: 50.10 (-0.03), CELG: 136.24 (+1.01)
What Are Portfolio Managers Afraid Of?
at The Street - Thu Jul 16, 1:51PM CDT
They should learn to trust techs, financials.
DAL: 44.65 (+0.56), FB: 98.39 (+0.48), C: 59.10 (+0.25), PFE: 35.14 (-0.10), BAC: 18.08 (-0.04), WFC: 57.95 (-0.10), GSK: 42.63 (-0.39), INTC: 28.72 (-0.38), CSX: 31.86 (-0.14), HPQ: 30.66 (+0.21), ORCL: 39.57 (-0.36), PEP: 96.93 (-0.38), CELG: 136.24 (+1.01), NFLX: 112.51 (+1.96), GS: 211.50 (-0.89), NOW: 78.57 (-0.27), JPM: 69.10 (-0.16), IBM: 163.07 (-10.15), MRK: 58.67 (-0.33), RCPT: 228.98 (+0.26), MSFT: 47.28 (+0.36), DATA: 127.57 (-0.58), CRM: 73.83 (+1.06)
Why I Won't Chase Netflix or Celgene Now
at The Street - Thu Jul 16, 12:11PM CDT
It's like buying at the top -- and I don't like buying at the top.
NFLX: 112.51 (+1.96), RCPT: 228.98 (+0.26), CELG: 136.24 (+1.01)
